Abstract

In 1988, we have drawn attention to the consistent finding of raised levels of interferon-alpha (IFN) in the cerebro-spinal fluid (CSF) and serum of infants affected with a severe genetically determined encephalopathy. These encephalopathies called Aicardi-Goutières syndrome (AGS) are characterized by calcifications of the basal ganglia, white matter demyelination and elevated levels of lymphocytes in the cerebrospinal fluid. These features mimic those of acquired in utero viral infection, so that AGS is sometimes mistaken for the sequelae of congenital infection. This diagnostic distinction has obvious importance, given that AGS is an autosomal recessive disorder whose true nature is often only recognized upon the birth of a second affected child. Recent molecular advances have shown that AGS can be caused by mutations in any one of at least five genes. The relationship between the involved disrupted nuclease pathways and the production of IFN leading to CNS damage in AGS is discussed.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.